NCT07084909 2025-12-10
HARRIER
Lantheus Medical Imaging
Phase 2/3 Withdrawn
Clinical Trials
5 trialsNCT02883153 2017-06-19
Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma
Radboud University Medical Center
Phase 2/3 Completed
NCT02829775 2017-01-09
A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies
Hoffmann-La Roche
Phase 2/3 Completed
NCT00420888 2015-07-22
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Active Biotech AB
Phase 2/3 Completed
NCT02030717 2015-06-04
ASA
Umeå University
Phase 2/3 Completed